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和肿瘤光热治疗。在这个系统中，经 Cy5.5 荧光信号与纳米颗粒内部 CuS 发生淬
灭，直到整个纳米颗粒被透明质酸酶分解，荧光才得以恢复。此外，尾静脉注射






CPGA 可以被金属基质蛋白酶 MMP-14 分解，从而使荧光得以恢复。研究还发现





































It is well known that cancer has become a major problem in the field of human 
health. The clinical study find that early diagnosis and treatment are useful methods to 
control and treat tumor. It has become a hot topic in these research to achieve early 
diagnosis of tumors as well as improve the therapeutic effect. Nanomedicine, the 
application of nanotechnology in medicine, promotes development of liposomes, 
nanoparticles, micelles and other drug-loaded nanoparticles. Above all, these materials 
in nanomedicine as effective theranostic agents can be used for diagnosis and therapy 
of various diseases. An ideal nanomaterial will provide: (1) early visualization of 
tumors or other disease sites, (2) effective delivery of drugs into the site of interest, (3) 
distribution of the theranostic agent in vivo, and (4) optimized therapeutic strategy to 
reduce adverse side effects. Therefore, excellent nanomaterials play an important role 
in diagnosis and treatment fields. 
In the second chapter, we developed a multifunctional nanocomposite by loading 
copper sulﬁde (CuS) into Cy5.5-conjugated hyaluronic acid nanoparticles (HANP), 
forming an activatable Cy5.5-HANP/CuS (HANPC) nanocomposite. CuS with strong 
NIR absorbance became an excellent contrast agent for photoacoustic (PAI) imaging 
and photothermal therapy (PTT). In this system, Cy5.5 ﬂuorescent signal was quenched 
by CuS inside the particle. when the whole nanocomposite was degraded by 
hyaluronidase, strong ﬂuorescence signals were monitored in the tumor site. After 
intravenous administration of HANPC into SCC7 tumor-bearing mice, high 
ﬂuorescence and PA signals were observed in the tumor site. In addition, tumors were 
then irradiated with a laser, and then an outstanding tumor inhibition rate was observed. 
In order to further improve the light conversion efficiency and tumor ablation effect 
of nanomaterials. In the third chapter, we developed a ﬂuorescent/PAI guided PTT agent 
by seeding Gold (Au) nanoparticles onto graphene oxide (GO). Near infrared dye 
labeled- matrix metalloproteinase-14 (MMP-14) substrate (CP) was conjugated onto 
the GO/Au complex (GA), forming activable tumor theranostic probe (CPGA). 
Quenched CPGA could be degraded by MMP-14, recovering fluorescence signal. We 
also fund that the photothermal effect of hybrid GA was found signiﬁcantly elevated 
compared with Au or GO alone. After the travenous administration of CPGA, high 















at the 6 h time point. an excellent tumor inhibition was then observed without 
recurrence. 
In summary, this paper described two activatable nanomaterials for theranostic 
integration. Our research encourage the biomedical application of these multifunctional 
nanocomposites, especially in the diagnosis and treatment of cancer. 
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图 1.1 基于脂质体和聚合物的纳米载体在药物转运和机体靶向中的应用。 
Figure 1.1 Lipid and polymer-based nanoparticulate systems used in the field of drug 



















载体受到广泛的关注[2, 3]。由于 HA 具有很强的亲水性，通过疏水性化合物 5β-胆
烷酸（CA）的疏水性修饰形成双亲性化合物。这种双亲性嵌段共聚物在极性溶
液中形成胶束。该胶束具有“核-壳”结构、药物缓释等、低临界胶束浓度特性，是




格便宜等优点。（2）HANP 独有的肿瘤双靶向作用，即 HANP 与肿瘤细胞膜表面
过度表达的 CD44 分子特异性结合，并通过细胞的内吞作用进入胞内，实现肿瘤
细胞的主动靶向性[5]；另一方面，HANP 的粒径约为 200 nm，能够通过实体瘤的
高通透性和滞留效应（EPR）被动聚集在肿瘤细胞，提高肿瘤靶性。通过双靶向
作用，大大提高了肿瘤对 HANP 及其装载药物的摄取[6]。（3）HANP 的体内可降
解性。HANP 被肿瘤细胞中透明质酸酶（主要是透明质酸酶 1 和 2）分解，释放
药物[7]。（4）HANP 为药物提供缓释作用，对治疗药物的水溶性也无严格限制。
这种药物含有亲水外壳可逃避单核巨噬细胞的吞噬，延长其血液半衰期[8]。（5）
HANP 含有大量的化学基团,可进行共价修饰[9]。因此 HANP 作为理想的智能可
降解纳米载体,具有广泛的医学应用前景。 
 
图 1.2 透明质酸纳米颗粒的细胞摄取通路和药物释放行为。 
Figure 1.2 Hyaluronic acid nanoparticle of hypothetical cellular uptake pathways and 
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